Literature DB >> 8876898

Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal cancer treated at the Singapore General Hospital.

K W Fong1, E J Chua, E T Chua, H S Khoo-Tan, K M Lee, K S Lee, V K Sethi, B C Tan, T W Tan, J Wee, T L Yang.   

Abstract

This is a report analysing the patient profile and survival results in 270 patients with nasopharyngeal carcinoma treated with radiation therapy between July 1987 and December 1988. The patients had a median age of 52.6 months, and a male-female ratio of 2.5:1. Ninety-four percent of patients were Chinese. The commonest presentation was that of a neck mass (found in approximately 65% of patients). Approximately two-thirds presented with disease more advanced than Ho's stage II. At a median follow-up of 52.6 months, the 5-year actuarial survival rate was 53% and the freedom from relapse rate was 57%. One hundred and seven patients died within the observation period. Of these, 46 patients had disease in the post nasal space, 41 in the neck and 60 in sites outside the head and neck.

Entities:  

Mesh:

Year:  1996        PMID: 8876898

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  8 in total

1.  The evolution of bone marrow signal changes at the skull base in nasopharyngeal carcinoma patients treated with radiation therapy.

Authors:  Safak Parlak; Gozde Yazici; Anil Dolgun; Burce Ozgen
Journal:  Radiol Med       Date:  2021-03-31       Impact factor: 3.469

2.  An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.

Authors:  Sik-Kwan Chan; Brian O'Sullivan; Shao Hui Huang; Tin-Ching Chau; Ka-On Lam; Sum-Yin Chan; Chi-Chung Tong; Varut Vardhanabhuti; Dora Lai-Wan Kwong; Chor-Yi Ng; To-Wai Leung; Mai-Yee Luk; Anne Wing-Mui Lee; Horace Cheuk-Wai Choi; Victor Ho-Fun Lee
Journal:  Cancers (Basel)       Date:  2022-04-11       Impact factor: 6.575

3.  Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.

Authors:  Z Liang; X Zhu; L Li; S Qu; X Liang; Z Liang; F Su; Y Li; W Zhao
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

4.  WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.

Authors:  Li Qin; Yan-Tao Yin; Fang-Jing Zheng; Li-Xia Peng; Chang-Fu Yang; Ying-Na Bao; Ying-Ying Liang; Xin-Jian Li; Yan-Qun Xiang; Rui Sun; An-Hua Li; Ru-Hai Zou; Xiao-Qing Pei; Bi-Jun Huang; Tie-Bang Kang; Duan-Fang Liao; Yi-Xin Zeng; Bart O Williams; Chao-Nan Qian
Journal:  Oncotarget       Date:  2015-04-30

5.  Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-Ethnic Society in Singapore.

Authors:  Han Wen Mak; Shan Hui Lee; Jeremy Chee; Ivan Tham; Boon Cher Goh; Siew Shuen Chao; Yew Kwang Ong; Kwok Seng Loh; Chwee Ming Lim
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

6.  Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.

Authors:  Lin Yang; Liangping Xia; Yan Wang; Shasha He; Haiyang Chen; Shaobo Liang; Peijian Peng; Shaodong Hong; Yong Chen
Journal:  BMC Cancer       Date:  2017-09-06       Impact factor: 4.430

7.  Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.

Authors:  Xiaoli Mu; Hongyan Liu; Juan Wu; Shi Chen; Xingchen Peng; Jingjing Wang; Zhigong Wei; Ling He; Jiyan Liu; Zejun Lu; Yonglin Su
Journal:  Aging (Albany NY)       Date:  2022-08-26       Impact factor: 5.955

8.  Serum- and glucocorticoid-inducible kinase 3 is a potential oncogene in nasopharyngeal carcinoma.

Authors:  Jing Chen; Hai Liang Li; Bo Bo Li; Wei Li; Dong Ma; Yong He Li; Tao Liu
Journal:  Braz J Otorhinolaryngol       Date:  2018-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.